Bayer Defends Aspirin Leadership While Eyeing Top OTC Spot
This article was originally published in The Tan Sheet
Executive Summary
Bayer boosted its marketing spend for aspirin during the third quarter in an effort to fend off competition in the cardio-aspirin category